Production of Mass-Separated Erbium-169 Towards the First Preclinical in vitro Investigations

Mostrar otras versiones (1)

The $\beta^-$-particle-emitting erbium-169 is a potential radionuclide toward therapy of metastasized cancer diseases. It can be produced in nuclear research reactors, irradiating isotopically-enriched $^{168}$Er$_2$O$_3$. This path, however, is not suitable for receptor-targeted radionuclide therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Talip, Zeynep, Borgna, Francesca, Müller, Cristina, Ulrich, Jiri, Duchemin, Charlotte, Ramos, Joao P, Stora, Thierry, Köster, Ulli, Nedjadi, Youcef, Gadelshin, Vadim, Fedosseev, Valentin N, Juget, Frederic, Bailat, Claude, Fankhauser, Adelheid, Wilkins, Shane G, Lambert, Laura, Marsh, Bruce, Fedorov, Dmitry, Chevallay, Eric, Fernier, Pascal, Schibli, Roger, van der Meulen, Nicholas P
Lenguaje:eng
Publicado: 2021
Materias:
Health Physics and Radiation Effects
Acceso en línea:https://dx.doi.org/10.3389/fmed.2021.643175
http://cds.cern.ch/record/2803707

Internet

https://dx.doi.org/10.3389/fmed.2021.643175
http://cds.cern.ch/record/2803707

Ejemplares similares